|1.||Wesołowska, Anna: 1 article (07/2006)|
|2.||Chojnacka-Wójcik, Ewa: 1 article (07/2006)|
|3.||Nikiforuk, Agnieszka: 1 article (07/2006)|
|4.||Miczek, K A: 1 article (05/2006)|
|5.||Benini, Q: 1 article (05/2006)|
|6.||De Almeida, R M M: 1 article (05/2006)|
|7.||Santos, D M: 1 article (05/2006)|
|8.||Rosa, M M: 1 article (05/2006)|
|9.||Saft, D M: 1 article (05/2006)|
07/10/2006 - "CP 94253 (10-40 mg/kg) afforded no protection against maximal electroshock-evoked convulsions, but produced anticonvulsant action in the pentylenetetrazol-induced seizures (ED50 = 29 mg/kg). "
07/10/2006 - "The obtained results suggest that CP 94253 exerts anticonvulsant activity on pentylenetetrazol-induced seizures in mice, as a consequence of stimulation of 5-HT1B receptors (probably located postsynaptically and/or as heteroreceptors); the antiseizure activity of RU 24969 seems to depend on the stimulation of both 5-HT1A and 5-HT1B receptors."
07/10/2006 - "The effect of the selective 5-hydroxytryptamine1B (5-HT1B) receptor agonist 5-propoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-pyrrolo[3,2-b]pyridine (CP 94253) and the 5-HT1A/1B/1D receptor agonist 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridyl)-1H-indole (RU 24969) in maximal electroshock- and pentylenetetrazol-induced seizures in mice was examined. "
|2.||Bites and Stings (Sting)
|3.||5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole